The Islamist terror regime, now allied to China and Russia, has been waging war against the United States for 47 years. But to Israel-bashers, it’s simply another Jewish plot. By Jonathan S. Tobin ...
- 4Q 2025 net income available to common shareholders of $100.2 million, or $2.79 Earnings per Share ("EPS"). Full year 2025 net income available to common shareholders of $406.9 million, or $11.40 ...
Initial Phase 1/2 trial data of vopimetostat in combination with Revolution Medicines’ RAS(ON) inhibitors in MTAP-deleted pancreatic cancer in 2026 with continued robust patient enrollment ...
ENDEAVOUR REPORTS STRONG FY-2025 RESULTS Record 2025 free cash flow of $1,156m l Record 2025 shareholder returns of $435m l >$1bn ...
Forward contract cover locked in for 99% of 2026 and 81% of 2027. Earnings, cashflow, forward visibility, and return of capital to shareholders materially increased y-o-y maximizing strategic ...